Open AccessMyoinositol In Restoring Spontaneous Ovarian Activity in Patients with Polycystic Ovarian Syndrome (PCOS)
Author(s) -
Ikram u-Allah,
Nadia Sabeen,
Qaiser Iqbal,
Shazia Zulfiqar,
Tayyiba Wasim
Publication year - 2020
Publication title -
esculapio
Language(s) - English
Resource type - Journals
eISSN - 2309-592X
pISSN - 2309-3080
DOI - 10.51273/esc20.2516310
Subject(s) - ovulation , medicine , menstrual cycle , gynecology , polycystic ovary , obstetrics and gynaecology , ovulation induction , obstetrics , anovulation , physiology , pregnancy , hormone , insulin resistance , biology , obesity , genetics
Objective: To assess the efficacy of myoinositol in the management of patients with Polycystic ovarian syndrome (PCOS) Methods: It was quasi experimental study conducted inDepartment of Obstetrics and Gynecology Services institute of Medical Sciences, Services Hospital, Lahore from 30-6-2018 to 31-12-2018. 140 sub fertile patients with PCOS were selected through random sampling. Patients were given 2gram of myoinositol/day. The effect was assessed after 3 and 6 months of treatment by monthly menstrual cycle regularity and ovulation. All this information was recorded in proforma. Results: The mean age of patients was 26.90±5.52years. The mean BMI of patients was 37.38±4.08kg/m2. After 3 months of treatment, menstrual cycle become regular in 34 (24.3%) patients and ovulation occurred in 54 (38.6%) cases. After 6 months of treatment, menstrual cycle become regular in 75 (53.6%) patients and ovulation occurred in 101 (72.1%) cases. Conclusion: The myoinositol is an effective treatment in terms of regularity of menstrual cycle and ovulation induction in subfertile women with PCOS. Keywords: Myoinositol, Polycystic ovarian syndrome, Menstrual irregularity, Ovulation